Abstract:Mycobacterial pathogens present a significant challenge to disease control efforts globally due to their inherent resistance to multiple antibiotics. The rise of drug-resistant strains of Mycobacterium tuberculosis has prompted an urgent need for innovative therapeutic solutions. One promising way to discover new tuberculosis drugs is by utilizing natural products from the vast biochemical space. Multidisciplinary methods can used to harness the bioactivity of these natural products. This study aimed to evaluate the antimycobacterial efficacy of functional crude extracts from bacteria isolated from gold mine tailings in South Africa. Bacterial strains were identified using 16S rRNA sequencing. The crude extracts obtained from the bacteria were tested against Mycobacterium tuberculosis H37Rv, Mycobacterium smegmatis mc 2 155, and Mycobacterium aurum A+. Untargeted HPLC-qTOF and molecular networking were used to identify the functional constituents present in extracts that exhibited inhibitory activity. A virtual screening workflow (VSW) was used to filter compounds that were strong binders to Mycobacterium tuberculosis Pks13 and PknG. The ligands returned from the VSW were subjected to optimization using density functional theory (DFT) at M06-2X/6-311++ ( d,p ) level of theory and basis set implemented in Gaussian16 Rev.C01. The optimized ligands were re-docked against Mycobacterium tuberculosis Pks13 and PknG. Molecular dynamics simulation and molecular mechanics generalized born surface area were used to evaluate the stability of the protein–ligand complexes formed by the identified hits. The hit that showed promising binding characteristics was virtually modified through multiple synthetic routes using reaction-driven enumeration. Three bacterial isolates showed significant activity against the two strains of Mycobacterium , while only two, Bacillus subtilis and Bacillus licheniformis , exhibited activity against both Mycobacterium tuberculosis H37Rv, Mycobacterium smegmatis mc 2 155, and Mycobacterium aurum A+. The tentatively identified compounds from the bacterial crude extracts belonged to various classes of natural compounds associated with antimicrobial activity. Two compounds, cyclo-(L-Pro-4-OH-L-Leu) and vazabitide A, showed strong binding against PknG and Pks13, with pre-MD MM-GBSA values of − 42.8 kcal/mol and − 47.6 kcal/mol, respectively. The DFT-optimized compounds exhibited the same docking scores as the ligands optimized using the OPSL-4 force field. After modifying vazabitide A, its affinity to the Pks13 binding site increased to − 85.8 kcal/mol, as revealed by the post-MD MM-GBSA analysis. This study highlights the potential of bacteria isolates from gold mine tailings as a source of new scaffolds for designing and optimizing anti- Mycobacterium agents. These agents synthesized in-silico can be further tested in-vitro to evaluate their efficacy.

Functional Selection of Aptamers That Inhibit Mycobacterium Tuberculosis Infection to Macrophages

Aptamer Inhibits Mycobacterium Tuberculosis (h37rv) Invasion of Macrophage

Aptamer from Whole-Bacterium SELEX As New Therapeutic Reagent Against Virulent Mycobacterium Tuberculosis

The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis.

Aptamer Against Mannose-capped Lipoarabinomannan Inhibits Virulent Mycobacterium Tuberculosis Infection in Mice and Rhesus Monkeys

Identification and application of ssDNA aptamers against H₃₇Rv in the detection of Mycobacterium tuberculosis.

Identification of Small Molecule Inhibitors against Mycobacteria in Activated Macrophages

[Selecting and Affinity Analysis of DNA Aptamers to MPT64 Protein from Mycobacterium Tuberculosis].

Selection of Aptamers to CFP10-ESAT6 Protein from Mycobacterium Tuberculosis

Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth

Dynamic Evolution and Immunoreactivity of Aptamers Binding to Polyclonal Antibodies Against MPT64 Antigen of Mycobacterium Tuberculosis.

Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria

Identification of Novel Antimicrobial Compounds Targeting Mycobacterium tuberculosis S-Adenosyl-L-Homocysteine Hydrolase Using Dual Hierarchical In Silico Structure-Based Drug Screening

In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis

Screening of Aptamers to CFP-10 Protein from Mycobacterium Tuberculosis

Screening and affinity analysis of aptamers to ESAT-6 protein from Mycobacterium tuberculosis

Genetics-directed Drug Discovery for Combating Mycobacterium Tuberculosis Infection

Target Prediction for an Open Access Set of Compounds Active Against Mycobacterium Tuberculosis

Discovery of benzo[c]phenanthridine derivatives with potent activity against multidrug-resistant Mycobacterium tuberculosis

Structure-guided identification and characterization of potent inhibitors targeting PhoP and MtrA to combat mycobacteria

Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system